Kunzli and Tager appear to suggest that the pollution exposure variable is not ecological because it is derived from measurement (i.e., it is a "crude, average ambient concentration"). It is true that Brenner et al. (2) state that in "ecologic studies, the exposure status of groups is often defined by the proportion of individuals exposed." Kunzli and Tager apparently missed the word "often" or interpreted it as "always." Brenner et al. (2) go on to indicate that exposure characterized by a single common measure such as "area air pollution" is an ecologic exposure variable.
We seem to agree that there are errors in using ambient concentrations as surrogate measures for individual exposure, that these errors influence the risk estimates, and that these are critical questions. We appear to disagree on how great is the effect, how to estimate the effect of these errors, and whether I have addressed the issues at all.
I discussed exposure misclassification, and I conduded that since all inhabitants in a given city are assumed to have the same exposure to PM25, there are large errors for many members of the cohorts (1). Therefore, the group-level exposure variable is not an adequate surrogate for personal exposure, and as a result, the risk estimates may be biased to an unknown extent and direction. The magnitude and direction of this misdassification bias cannot be easily estimated because it has been repeatedly shown that even apparently nondifferential misdassification can cause spurious results in either direction (3-) . In fact, when the true relative risk is near 1.00 (as is the case for PM), an appreciable percentage of studies will overestimate the risk (9) . When the true relative risk is exactly 1.00, the misclassified risk estimates are evenly distributed above and below 1 (5, (11) (12) (13) (14) (15) . Furthermore, for individual-level confounding to be effectively removed, the nature of the association between the exposure and the confounder should be well specified, which is not possible when exposure information for individuals is lacking.
Some questions regarding the inaccuracies associated with the risk estimates from these studies may be addressed in ways suggested by Kunzli and Tager. I go beyond these suggestions to propose that the ultimate validity of the risk estimates in these studies is basically unknown. The risk estimates must be verified or refuted by a different study design utilizing individual-level data for exposure, outcome, and confounding variables (1) .
This process of verification or refutation is an essential part of the scientific method in general and epidemiology in particular (16 It is unclear whether the SDA long-term morbidity results (10) are coherent with mortality results. Among individuals who were symptom-free at the start of the study, there was an association between increased symptoms and PM. These risk estimates were 40-fold greater than those estimated for smoking. There were no analyses presented for those individuals who had symptoms at the start of the study, but became symptom-free at the end of the study. This analysis is just as important as the analysis of incidence of new symptoms. If both showed an association with PM, the results would not be internally coherent (1) .
I presented evidence showing why reduced lung function could be a confounder in these studies and that it meets the criteria for confounding. First, reduced lung function must be a risk factor for increased mortality (1) . Second, reduced lung function must be correlated with between-city variations in PM2.5, although the relationship shown in Figure 3 (1) could only be tested with the ecologically based exposure measures used in that study. Third, reduced lung function should not be on the same causal pathway as PM2 5 for mortality; the point of the example shown in Figure 4 (1) was to suggest that important differences occur in the distribution of risk factors between cities, with lung function being one of many possible risk factors. I do not believe that adjustment for a few individual-level risk factors has adequately addressed the complex overall potential for confounding in these studies. We all realize that we can never make all groups completely comparable, but between-city differences in PM2 5 concentrations are so small and relative risks so low that these studies are particularly susceptible to even slightly confounded results.
I believe this paper (1) and the questions raised by Kuinzli and Tager are in line with the scientific process of verification and refutation. They have led to further discussion that will hopefully lead to additional testing. However, it is disappointing that Kunzli and Tager chose to question the integrity of the author's motivation based on affiliation. (1) was then fitted to the data for each of the three subgroups. Table 1 shows the regression coefficients for the logarithmic transformation of the cord-blood mercury concentration, i.e., the change in the outcome variable associated with a 10-fold increase in methylmercury exposure. The hypothesis of no difference between the regression coefficients was then tested, and in all cases resulted in an acceptance of the hypothesis, with p-values of 0.16-0.94. Accordingly, the effect of mercury exposure can be explained by three parallel lines. The hypothesis of no PCB effect resulted in p-values between 0.07 and 0.73, thus suggesting no difference in the intercept between the three lines. Thus, given the acceptance of both null hypotheses, the effect of mercury exposure on each of the five neurobehavioral outcome variables can be explained by a single line. All mercury regression coefficients for the control group suggest a deficit at increasing concentrations similar to the one for the overall material (1). Also, when compared to the two other tertile groups, the mercury effect in the control group was the greatest for three of five outcome variables However, some information may be lost, as the PCB exposure variable in this analysis was reduced to tertile classes only. Thus, the possible effect modification by PCB exposure was investigated in regression analyses, which in addition to the confounders, also included the mercury and PCB exposure variables as well as a product term between the two exposure biomarkers. The p-value for no effect modification was between 0.21
